Home › Funds › Morgan Stanley › TECH
Morgan Stanley position in TECH
BIO-TECHNE CORP · Health Care
Latest position (Q2 2026)6.37M sh
Reported value held$450.37M
Portfolio Weight0.03%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 115.47K | $55.95M | New |
| Q4 2021 | 95.17K | $49.23M | Reduce |
| Q1 2022 | 105.78K | $45.81M | Add |
| Q2 2022 | 230.60K | $79.94M | Add |
| Q3 2022 | 212.99K | $60.49M | Reduce |
| Q4 2022 | 2.98M | $247.20M | Add |
| Q1 2023 | 3.18M | $236.23M | Add |
| Q2 2023 | 3.16M | $258.12M | Reduce |
| Q3 2023 | 3.31M | $225.03M | Add |
| Q4 2023 | 4.09M | $315.44M | Add |
| Q1 2024 | 4.19M | $294.95M | Add |
| Q2 2024 | 4.41M | $316.03M | Add |
| Q3 2024 | 4.66M | $372.28M | Add |
| Q4 2024 | 4.76M | $342.76M | Add |
| Q1 2025 | 5.72M | $335.34M | Add |
| Q1 2025 | 5.72M | $335.34M | Add |
| Q2 2025 | 6.58M | $338.49M | Add |
| Q2 2025 | 6.58M | $338.49M | Add |
| Q3 2025 | 7.24M | $402.64M | Add |
| Q4 2025 | 8.35M | $490.79M | Add |
| Q1 2026 | 8.53M | $445.93M | Add |
| Q2 2026 | 6.37M | $450.37M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TECH
- Vanguard Group 17.81M sh · $1.05B · Q4 2025
- BlackRock Inc 14.03M sh · $990.92M · Q2 2026
- Fidelity Management & Research (FMR) 12.79M sh · $903.95M · Q2 2026
- Goldman Sachs Group 7.34M sh · $518.81M · Q2 2026
- Geode Capital Management 5.35M sh · $377.54M · Q2 2026
- Invesco Ltd 4.99M sh · $352.29M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- MFS Investment Management 2.75M sh · $194.01M · Q2 2026
- Capital Research Global Investors 2.62M sh · $185.24M · Q2 2026
- UBS Group AG 2.48M sh · $175.11M · Q2 2026
- JPMorgan Chase & Co 1.86M sh · $132.60M · Q2 2026